Clinical Outcomes of Cabozantinib in Patients Previously Treated with Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma—Importance of Good Liver Function and Good Performance Status.

Autor: Kuzuya, Teiji1 (AUTHOR) kawabe@fujita-hu.ac.jp, Kawabe, Naoto1 (AUTHOR) a.mizuki0909@gmail.com, Ariga, Mizuki1 (AUTHOR) eizaburo.ono@fujita-hu.ac.jp, Ohno, Eizaburo1 (AUTHOR) k-funa@fujita-hu.ac.jp, Funasaka, Kohei1 (AUTHOR) nmitsu@fujita-hu.ac.jp, Nagasaka, Mitsuo1 (AUTHOR) yo-hi@fujita-hu.ac.jp, Nakagawa, Yoshihito1 (AUTHOR) ryoji.miyahara@fujita-hu.ac.jp, Miyahara, Ryoji1 (AUTHOR) shibat03@fujita-hu.ac.jp, Shibata, Tomoyuki1 (AUTHOR), Takahara, Takeshi2 (AUTHOR) takahara731026@yahoo.co.jp, Kato, Yutaro2 (AUTHOR), Hirooka, Yoshiki1 (AUTHOR)
Zdroj: Cancers. Jun2023, Vol. 15 Issue 11, p2952. 14p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje